ES2061539T3 - Procedimiento para la fabricacion de acidos quinolonacarboxilicos administrables parenteralmente. - Google Patents

Procedimiento para la fabricacion de acidos quinolonacarboxilicos administrables parenteralmente.

Info

Publication number
ES2061539T3
ES2061539T3 ES88105766T ES88105766T ES2061539T3 ES 2061539 T3 ES2061539 T3 ES 2061539T3 ES 88105766 T ES88105766 T ES 88105766T ES 88105766 T ES88105766 T ES 88105766T ES 2061539 T3 ES2061539 T3 ES 2061539T3
Authority
ES
Spain
Prior art keywords
acids
chinolonacarboxylic
procedure
manufacture
parenterally administrable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88105766T
Other languages
English (en)
Inventor
Michael Dr Preiss
Ulrich Dr Schorsch
Arthur Dr Haaf
Paul Dr Naab
Rudolf Dr Zerbes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6326178&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2061539(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer AG filed Critical Bayer AG
Application granted granted Critical
Publication of ES2061539T3 publication Critical patent/ES2061539T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Quinoline Compounds (AREA)

Abstract

LA INVENCION SE REFIERE A SOLUCIONES ADMINISTRABLES PARENTERALMENTE DE ACIDOS QUINOLONCARBOXILICOS DE FORMULA GENERAL (I) EN LA QUE R1, R2, R3, X Y A TIENEN EL SIGNIFICADO DADO EN LA DESCRIPCION, ASI COMO UN PROCEDIMIENTO PARA SU OBTENCION.
ES88105766T 1987-04-24 1988-04-12 Procedimiento para la fabricacion de acidos quinolonacarboxilicos administrables parenteralmente. Expired - Lifetime ES2061539T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873713672 DE3713672A1 (de) 1987-04-24 1987-04-24 Verfahren zur herstellung von parenteral verabreichbaren chinoloncarbonsaeuren

Publications (1)

Publication Number Publication Date
ES2061539T3 true ES2061539T3 (es) 1994-12-16

Family

ID=6326178

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88105766T Expired - Lifetime ES2061539T3 (es) 1987-04-24 1988-04-12 Procedimiento para la fabricacion de acidos quinolonacarboxilicos administrables parenteralmente.

Country Status (7)

Country Link
US (1) US4973590A (es)
EP (1) EP0287926B1 (es)
JP (1) JP2848527B2 (es)
KR (1) KR960012398B1 (es)
AT (1) ATE97807T1 (es)
DE (2) DE3713672A1 (es)
ES (1) ES2061539T3 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3902079A1 (de) * 1988-04-15 1989-10-26 Bayer Ag I.m. injektionsformen von gyrase-inhibitoren
US5262417A (en) * 1988-12-06 1993-11-16 The Upjohn Company Antibacterial quinolone compounds
US5324735A (en) * 1989-07-21 1994-06-28 Ss Pharmaceutical Co., Ltd. Quinoline carboxylic acid derivatives
US5385913A (en) * 1989-10-06 1995-01-31 Pfizer Inc. 1,4-dihydro-4-oxo-3-quinoline derivatives as selectively toxic mammalian antibacterial agents
FI921475A7 (fi) * 1989-10-06 1992-04-03 Pfizer 1,4-dihydro-4-okso-3-kinoliinijohdannaisia selektiivisesti toksisina n isäkkään antibakteerisina aineina
AU647772B2 (en) * 1989-12-29 1994-03-31 Abbott Laboratories Quinolone carboxylic acid--metal ion--acid complexes
JP2613139B2 (ja) * 1990-07-19 1997-05-21 エスエス製薬 株式会社 キノロンカルボン酸誘導体
US5290794A (en) * 1992-10-27 1994-03-01 Warner Lambert Co. Soluble calcium lactate antibacterial complexes as non-irritating parenteral forms
FR2703681B1 (fr) * 1993-04-08 1995-05-12 Bellon Labor Sa Roger Procede de preparation de fluoro-6-halogeno-2 quinoleine
DE4338564A1 (de) * 1993-11-05 1995-05-11 Priamos Licht Ind & Dienstleis Steuerschaltung für Halb- oder Vollbrückenwechselrichter
US5800833A (en) * 1995-02-27 1998-09-01 University Of British Columbia Method for loading lipid vesicles
US5602254A (en) * 1995-05-26 1997-02-11 Warner-Lambert Company Method for making quinoline carboxylic acids or naphthyridine carboxylic acids in free base form
DE19730023A1 (de) * 1997-07-11 1999-01-14 Bayer Ag Hochreine Ciprofloxacin-Infusion
HN1998000106A (es) 1997-08-01 1999-01-08 Pfizer Prod Inc Composiciones parenterales de alatroflaxacino
US6423741B1 (en) * 1998-07-10 2002-07-23 Council Of Scientific And Industrial Research Anti-microbial composition and method for producing the same
RU2161966C1 (ru) * 2000-02-14 2001-01-20 Общество с ограниченной ответственностью "Поливит" Антимикробное средство
DE102004005186B3 (de) * 2004-02-02 2005-10-13 Krka Tovarna Zdravil, D.D. Verfahren zur Herstellung von gereinigtem Ciprofloxacin
DE102004054873A1 (de) 2004-11-12 2006-05-18 Bayer Healthcare Ag Behandlung von Mastitis
DE102005055385A1 (de) * 2004-12-09 2006-06-14 Bayer Healthcare Ag Arzneimittel zur hygienischen Applikation im Ohr
CA2591296A1 (en) * 2004-12-09 2006-06-15 Bayer Healthcare Ag Stabilisation of glucocorticoid esters with acids
DE102006010643A1 (de) * 2006-03-08 2007-09-13 Bayer Healthcare Aktiengesellschaft Arzneimittel enthaltend Fluorchinolone

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1175836A (en) * 1977-09-20 1984-10-09 Marcel Pesson Production of 1,4-dihydroquinoline-3-carboxylic acid derivatives
SE444566B (sv) * 1977-09-20 1986-04-21 Bellon Labor Sa Roger 7-dialkylamin-6-halogen-4-oxo-1,4-dihydrokinolin-3-karboxylsyra, forfarande for framstellning derav och farmaceutiskt preparat derav
DE3033157A1 (de) * 1980-09-03 1982-04-01 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-naphthyridin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3142854A1 (de) * 1981-10-29 1983-05-11 Bayer Ag, 5090 Leverkusen 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7-piperazino-chinolin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
US4638067A (en) * 1982-09-09 1987-01-20 Warner-Lambert Co. Antibacterial agents
DE3333719A1 (de) * 1983-09-17 1985-04-04 Bayer Ag Loesungen milchsaurer salze von piperazinylchinolon- und piperazinyl-azachinoloncarbonsaeuren
US4616019A (en) * 1984-01-26 1986-10-07 Abbott Laboratories Naphthyridine antibacterial compounds
DE3420116A1 (de) * 1984-05-30 1985-12-05 Bayer Ag, 5090 Leverkusen Immunstimulierende mittel
JPS61180771A (ja) * 1985-01-05 1986-08-13 バイエル・アクチエンゲゼルシヤフト 安定な抗バクテリア剤水溶液

Also Published As

Publication number Publication date
EP0287926B1 (de) 1993-12-01
US4973590A (en) 1990-11-27
DE3713672A1 (de) 1988-11-17
EP0287926A3 (en) 1990-05-09
JP2848527B2 (ja) 1999-01-20
KR960012398B1 (ko) 1996-09-20
ATE97807T1 (de) 1993-12-15
EP0287926A2 (de) 1988-10-26
DE3885928D1 (de) 1994-01-13
JPS63280068A (ja) 1988-11-17
KR880012230A (ko) 1988-11-26

Similar Documents

Publication Publication Date Title
ES2061539T3 (es) Procedimiento para la fabricacion de acidos quinolonacarboxilicos administrables parenteralmente.
GR3004925T3 (es)
TW279865B (es)
MA22481A1 (fr) Procede de preparation d'acides imidazolyl - alcenoiques .
ZA857274B (en) Diarylacetylenes,their preparation and their use
GR75859B (es)
EP0387821A3 (de) 2-Alkyl-4-arylmethylaminochinoline, ihre Verwendung und daraus hergestellte Arzneimittel
FI882669L (fi) Menetelmä farmaseuttisesti aktiivisten alfa-halogenoitujen dikarboksyylihappojen valmistamiseksi
FR2670206B1 (fr) Procede de preparation de derives de l'acide dihydroxy-3,5 pentanouique.
PT87563A (pt) Process for the preparation of vinylcephalosporins useful as medicaments
EP0234348A3 (en) N-glycosyl amide derivatives, method for their preparation and their use as medicaments
AU553874B2 (en) Thiazaspirane derivatives
GR3001542T3 (en) Benzofuran carboxamides with basic substituents, process for their preparation and therapeutical compositions containing them
HUT49846A (en) Process for producing n-(3',4'-dimethoxycinnamoyl)-anthranilic acid (tranilast)
AU1745288A (en) Process for the preparation of 4,4'-dinitrostilbene-2,2'-disulfonic acid
DE3273979D1 (en) 9,10-substituted 2-mesitylimino-3-alkyl-3,4,6,7-tetrahydro-2h-pyrimido(6,1-a)isoquinolin-4-ones, process for their preparation and their use as medicaments
PT88294A (pt) Processo para a preparacao de derivados de fenantridina
GR3002884T3 (en) Substituted chinoxalyl-imidazolidine-2,4-diones, process for their preparation, their use as medicaments and pharmacological preparations
EP0460544A3 (en) Process for the preparation of sulphonated anthranilic acids
HUT44802A (en) Process for producing pseudo-oligosaccharides and pharmaceutical compositions containing them
DE3362130D1 (en) 7-phenyl-7-phenoxymethyl-hexahydro-1,4-oxazepines, their preparation and use
FI892911A0 (fi) Menetelmä terapeuttisesti käyttökelpoisen (+)-1-/(3,4,5-trimetoksi)bentsyylioksimetyyli/-1-fenyyli-N,N-dimetyyli-n-propyyliamiinin valmistamiseksi
HUT49886A (en) Process for producing new beta-lactam antibiotics and pharmaceutical compositions comprising same
FI902157A7 (fi) Menetelmä 1,6-hekseenidiohappojen valmistamiseksi
HU9202787D0 (en) New intermediary products and their utilization for producing s-ketoprophene

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 287926

Country of ref document: ES